MC
CELG

Miramar Capital’s Celgene Corp CELG Stock Holding History

Miramar Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,630
Closed -$375K – 64
2019
Q3 		$375K Sell
3,630
-100
-3% -$9.5K 0.25% 39
2019
Q2 		$344K Buy
3,730
+100
+3% +$9.5K 0.24% 43
2019
Q1 		$342K Sell
3,630
-200
-5% -$17.5K 0.26% 44
2018
Q4 		$341K Buy
+3,830
New +$283K 0.27% 46

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Miramar Capital's CELG Position: Q4 2019 in Review

Miramar Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,630 shares — an estimated $375K sold.

Miramar Capital first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $375K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Miramar Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Miramar Capital sold 3,630 Celgene Corp shares in Q4 2019, an estimated $375K.
  • Miramar Capital first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Miramar Capital's Celgene Corp position peaked at $375K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Miramar Capital's 13F filing for Q4 2019, filed 5 Feb 2020.